Friday, September 29, 2006
Thursday, September 28, 2006
As an investor you have to love an article like this one. The Motley Fool wonders if CuraGen is "Hiding a Genomic Gem" in the race to find the $1000 genome. Which is important, because it helps with making designer drugs for individual people. At around $3.50, Curagen is worth a look if anything.
Friday, September 15, 2006
TINY - Harris & Harris Group, Inc. is a venture capital firm investing in nano technology companies. My interest has been sparked of late due to a rise in price in the stock and numerous news articles naming nano technology as the big thing for the future. This is the only pure play in the sector, and a very very long long term play, which may make you rich some day.